Vegfxta 100 mg Injection
  1. Home
  2. Pharma Products
  3. Fresenius Kabi India Pvt Ltd
  4. Vegfxta 100 mg Injection

Vegfxta 100 mg Injection

Vegfxta 100 mg Injection contains bevacizumab 100 mg and is an anticancer medicine used for the treatment of several advanced cancers. It is supplied as a 100 mg/4 mL solution in a single-use vial for intravenous infusion under medical supervision. Bevacizumab blocks vascular endothelial growth factor A (VEGF-A), helping reduce the formation of blood vessels that support tumor growth.

BUY NOW

Category

Vegfxta may be used with other anticancer medicines for conditions such as colorectal cancer, non-small cell lung cancer, kidney cancer, cervical cancer, and certain ovarian and peritoneal cancers. By targeting VEGF-A, it interferes with tumor angiogenesis and can limit the blood supply available to growing tumors. The medicine is administered through intravenous infusion, with the dose and treatment schedule selected according to the cancer type and prescribed regimen. Appropriate monitoring is required during treatment because bevacizumab can be associated with hypertension, bleeding, proteinuria, impaired wound healing, and other clinically important reactions.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 100 mg
Presentation 100 mg/4 mL
Concentration 25 mg/mL
Dosage Form Solution for intravenous infusion
Manufacturer/Marketer Fresenius Kabi India Pvt Ltd

Product Also Known As

Vegfxta 100mg Injection, Vegfxta 100mg/4ml Injection, Bevacizumab 100mg Injection, Bevacizumab 100mg/4ml Infusion, Bevacizumab Injection 100mg, Bevacizumab 25mg/ml Infusion